J.Perinat. Med. 8 (1980) 203 Prenatal diagnosis and therapy of fetal heart rate anomalies: With a contribution on the placental transfer of Verapamil The prenatal fetal diagnosis of heart rate anomalies is made by fetal electrocardiography [l, 2] . Arrhythmias äs well äs heart rate anomalies have been described; incidence and clinical significance have been reported elsewhere [l, 2, 11] . In this study of three individual cases the diagnosis and therapy of fetal heart rate anomalies will be discussed. In one of the cases a paroxysmal fetal tachycardia was treated successfully. One of the drugs used was Verapamil and its use offered the opportunity to investigate its placental transfer which had previously been unknown in the human. 
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Dr
l Cases
Case 1: M.W., 21 year-old II Para after Cesarean Section three years before. She was admitted one day before her due date because a fetal bradycardia was noted on auscultation. The cardiogram demonstrated a persistent fetal bradycardia of 70 to 80 beats/minute. The fetal ECG (Fig. 1 ) documented a bradycardia with a rate of 72 to 78 beats/minute. An AV block was suspected. On the next day labor began and a Cesarean section was 0300-5577/80/0008-0203$02.00performed. A healthy appearing boy with a birth weight of 3400 gram, length 51 cm, APGAR score 8 at one minute was born. An electrocardiogram obtained immediately after birth ( fig. l, below) confirmed the complete AV block with complete dissociation of atrial and ventricular activity. The AV block converted spontaneously into a normal conduction after one week; no cause of the rhythm disturbance was found. Case 2: A.S., 27 year-old primigravida four days before her EDC. A fetal ECG demonstrated extrasystoles ( Fig. 2 ) with a rate of 132 to 156 beats/ minute. Because of the fetal maturity and a favorable cervix (BiSHOP score 5) the birth was induced with amniotomy and oxytocin infusion (8 mE/ min). Fetal heart rate was recorded continuously from a scalp electrode and labor was recorded from intra-amniotic pressure recordings (HewlettPackard cardiotocograph 8030A). During delivery irregularly occurring exträsystoles were seen on the osciüoscope, simultaneously the recorder registered unidirectional excursions of constant amplitude without pen-lift (Fig. 3) (Fig. 4 ) documented a fetal tachy-arrhythmia with a rate between 264 and 282 beats/minute. This rate was documented sonographically with a time-motion recording ( Fig. 6 ).
From the ultrasonogram ascites was suspected äs indication for early cardiac failure (Fig. 5) ; therefore the m other was treated with 0-acetyldigoxin and Verapamil. 0-acetyldigoxin following loading was maintained with a dose of 0.4 mg per day and the dose of Verapamil was 80 mg three times daily. During the four days after onset of treatment the tachy-arrhythmia slowed transiently to 180-196 per minute. Five days after complete digitalization and administration of Veramapil the fetal heart rate was normal with a rate of 138-150 per minute. This rate persisted while therapy was continued until delivery in the 39th week of pregnancy. Delivery was induced three days before the due date. The infant (3200 grams, 49 cm, APGAR score 9) had a sinus rhythm with the rate of 160-170 per minute during the first days of life. There were no signs of cardiae hypertrophy or disturbances in repolarisation. The AV conduction time was normal. Since in contrast to digoxin the Veramapil had not been shown to pass through the placenta in the human we investigated the placental passage of this substance during treatment. 
Pharmacokinetics of Verapamil 2.1 Materials and methods
Six pregnant women whose deliveries were induced at term with a mature fetus and favorable cervix received during the first phase of labor 80 mg of Verapamil orally when the cervical dilation was 3-4 cm. Infants were born between 49 and 564 minutes after the drug administration. Blood was obtained immediately after birth from the antecubital vein and the umbilical vein. Plasma samples were analyzed for concentration of Verapamil in a gas Chromatograph with the nitrogen specific flame ionization detector [4] . The lower limit of sensitivity is 4 ng/ml Verapamil. ,2.2 Results (Tab. I)
In the maternal plasma Verapamil was found up to 173 minutes after an oral dose of 80 mg. After three hours the Verapamil levels were below the detectable levels. Verapamil was found at levels of 15.4 and 24.5 ng/ml after 49 and 109 minutes. No detectable amounts of the drug were found in samples obtained later.
Discussion
The diagnosis of fetal heart rate anomalies is made from the fetal ECG. Because of physiologically low voltage it may in exceptional cases be difficult between the 29th and 35th week of gestation [l, 2] . Changes of cardiac rhythm such äs a complete AV block or paroxsymal tachycardia may be recorded with the generally available cardiotocographs if the rates are not outside the ränge of 50-210 beats per minute. However, cardiotocograph will allow the rec^gnition of rhythm anomalies only in cases in which the fetal Signals are not rejected by the logic-circuitry which analyses Signals in respect to artifacts.
Prenatally recorded fetal arrhythmiäs are not found after birth in 85% of the newborns. Persistent rhythm anomalies are associated with cardiac defects in less than 3% of cases [1, 2] . The clinical importance of the diagnosis of fetal rhythm anomalies is emphasized by the fetal paroxysmal tachycardia described above. WOOD [10] has shown that a persistent paroxysmal tachycardia may lead to a myocardial insufficiency. Therefore, signs of cardiac decompensation such äs the sonographic documentation of ascites in the fetal abdomen should be looked 1 for. Paroxysmal tachycardias are almost exclusively of supraventricular origin. The treatment consists of the use of Verapamil in combination with digitalis to the mother [6, 7, 8] . This treatment brings about a normalization of the heart rate by inhibiting AV conduction and Prolongation of the refactory time [7] . VALERIUS [11] in 1978 was the first to report a successful treatment of fetal supraventricular tachycardia by maternal digitalization. In our case we treated with 0-acetyldigoxin and Verapamil in the dosages mentioned and fetal heart rate because normal during treatment. The basis for the treatment were studies on the placental transfer of the two drugs used. ROGERS [5] demonstrated that digoxin concentrations in the umbilical biood was the same äs that in the maternal blood in women who received longterm digitalis treatment because of heart disease. Therefore, a free transfer of digoxin must be assumed. The placental transfer of Verpamil in humans has not been investigated before. We were able to demonstrate placental transfer after a one time dose of 80 mg of Verapamil during delivery. This confirmed animal experiments by STRIGL [9] . Concentration in the fetus after one time oral administration to the mother were 15.4 ng/ml after 49 minutes and 24.5 ng/ml plasma after 109 minutes. Thus, the concentrations in the infant are markedly less than in the matemal plasma. With larger time intervals between administration and delivery no Verapamil was detected in the cord blood. The question remains open whether pharmacologically effective drug levels were achieved in the fetus while administering 240 mg of Verapamil per day.
Summary
This study discusses the diagnosis and therapeutic possibilities of fetal heart rate anomalies in light of three case reports. A complete AV block which persisted after birth converted to normal rhythm without treatment. In the second case extrasystoles in the fetus were not present in the newborn. The third case of heart rate anomaly was a paroxysmal tachy-arrhythmia with a rate of 264-282 per minute which was observed for ten days. In all cases the diagnosis was made with a prenatal fetal ECG. The first two disturbances were also recorded with the cardiotogram. The fetal extrasystole was manifest in the cardiotocogram by unidirectional excusions of the pen with constant amplitude and simultaneous extrasystoles on the oscilloscope. In the third case of a fetal paroxysmal tachycardia the cardiotocograph did not record the arrhythmia because the rate exceeded the ränge of the cardiotocograph. Because of a fetal caidiac insufficiency the mother was treated with 0-acetyldigoxin and Verapamil. During this therapy the fetal heart rate became normal until delivery. We investigated the placental transfer of Verapamil because it had not been investigated previously in humans. The concentration in the umbilical venous blood 49 and 109 minutes after administration of 80 mg Verapamil to the mother was 15.4 and 24.5 ng/mlrespectively; these levels were less than those in the maternal plasma. At longer intervals between administration and delivery the Verapamil levels in the umbilical venous blood was below a detectable level. Therefore, it has been shown that Verapamil passes through the placenta.
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